Investing.com - Pfizer reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Pfizer announced earnings per share of $2.04 on revenue of $27.74B. Analysts polled by Investing.com EPS of $1.71 on revenue of $25.26B.
Pfizer 's are down 12% and is trading at $51.95 , still down 15.82% from its 52 week high of $61.71 set on Monday, December 20, 2021.
Pfizer follows other major Healthcare sector earnings this month
Pfizer's report follows an earnings beat by UnitedHealth on Friday, July 15, 2022, who reported EPS of $5.57 on revenue of $80.33B, EPS of $5.21 on revenue of $79.68B.
J&J had beat expectations on Tuesday, July 19, 2022 with second quarter EPS of $2.59 on revenue of $24.02B, for EPS of $2.54 on revenue of $23.77B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar